# FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

> **NCT06472661** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Virginia** · enrollment: 11 (estimated)

## Conditions studied

- Advanced Melanoma

## Interventions

- **DEVICE:** Echopulse or Echopulse HD
- **DRUG:** PolyICLC

## Key facts

- **NCT ID:** NCT06472661
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-27
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472661, "FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06472661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*